DR Horton Stock London S.E.

Equities

0I6K

US23331A1097

Homebuilding

Market Closed - London S.E. 10:57:04 2024-04-16 am EDT 5-day change 1st Jan Change
145.1 USD -7.23% Intraday chart for DR Horton -4.21% -4.51%
Sales 2024 * 36.92B Sales 2025 * 39.41B Capitalization 47.63B
Net income 2024 * 4.72B Net income 2025 * 5B EV / Sales 2024 * 1.33 x
Net Debt 2024 * 1.36B Net Debt 2025 * 1.02B EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
10.2 x
P/E ratio 2025 *
9.31 x
Employees 13,450
Yield 2024 *
0.83%
Yield 2025 *
0.89%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day-7.23%
1 week-4.21%
Current month+1.05%
1 month-0.67%
3 months-1.12%
6 months+13.77%
Current year-4.51%
More quotes
1 week
142.87
Extreme 142.87
151.93
1 month
141.21
Extreme 141.205
157.08
Current year
139.18
Extreme 139.18
165.17
1 year
100.28
Extreme 100.28
165.17
3 years
59.29
Extreme 59.29
165.17
5 years
30.82
Extreme 30.82
165.17
10 years
30.82
Extreme 30.82
165.17
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 98-12-31
Chairman 68 87-12-31
Director of Finance/CFO 58 97-12-31
Members of the board TitleAgeSince
Director of Finance/CFO 58 97-12-31
Director/Board Member 78 14-01-22
Director/Board Member 73 21-04-19
More insiders
Date Price Change Volume
24-05-24 144.3 +0.91% 189
24-05-23 143 -1.74% 859
24-05-22 145.5 -2.45% 718
24-05-21 149.1 -0.85% 385
24-05-20 150.4 -0.69% 613

Delayed Quote London S.E., April 16, 2024 at 10:57 am EDT

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
144.6 USD
Average target price
169.8 USD
Spread / Average Target
+17.41%
Consensus